ACRV
Price
$1.33
Change
-$0.00 (-0.00%)
Updated
Aug 29, 03:23 PM (EDT)
Capitalization
42.78M
69 days until earnings call
AURA
Price
$6.43
Change
-$0.01 (-0.16%)
Updated
Aug 28 closing price
Capitalization
399.43M
69 days until earnings call
Interact to see
Advertisement

ACRV vs AURA

Header iconACRV vs AURA Comparison
Open Charts ACRV vs AURABanner chart's image
Acrivon Therapeutics
Price$1.33
Change-$0.00 (-0.00%)
Volume$927
Capitalization42.78M
Aura Biosciences
Price$6.43
Change-$0.01 (-0.16%)
Volume$113.38K
Capitalization399.43M
ACRV vs AURA Comparison Chart in %
Loading...
ACRV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACRV vs. AURA commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRV is a StrongBuy and AURA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (ACRV: $1.33 vs. AURA: $6.43)
Brand notoriety: ACRV and AURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACRV: 36% vs. AURA: 64%
Market capitalization -- ACRV: $42.78M vs. AURA: $399.43M
ACRV [@Biotechnology] is valued at $42.78M. AURA’s [@Biotechnology] market capitalization is $399.43M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACRV’s FA Score shows that 1 FA rating(s) are green whileAURA’s FA Score has 1 green FA rating(s).

  • ACRV’s FA Score: 1 green, 4 red.
  • AURA’s FA Score: 1 green, 4 red.
According to our system of comparison, both ACRV and AURA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACRV’s TA Score shows that 4 TA indicator(s) are bullish while AURA’s TA Score has 2 bullish TA indicator(s).

  • ACRV’s TA Score: 4 bullish, 4 bearish.
  • AURA’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, ACRV is a better buy in the short-term than AURA.

Price Growth

ACRV (@Biotechnology) experienced а +0.76% price change this week, while AURA (@Biotechnology) price change was -0.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was +15.08%, and the average quarterly price growth was +29.42%.

Reported Earning Dates

ACRV is expected to report earnings on Nov 06, 2025.

AURA is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (-1.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AURA($399M) has a higher market cap than ACRV($42.8M). AURA YTD gains are higher at: -21.776 vs. ACRV (-77.907). ACRV has higher annual earnings (EBITDA): -93.21M vs. AURA (-107.51M). AURA has more cash in the bank: 177M vs. ACRV (137M). ACRV has less debt than AURA: ACRV (3.26M) vs AURA (18.1M). ACRV (0) and AURA (0) have equivalent revenues.
ACRVAURAACRV / AURA
Capitalization42.8M399M11%
EBITDA-93.21M-107.51M87%
Gain YTD-77.907-21.776358%
P/E RatioN/AN/A-
Revenue00-
Total Cash137M177M77%
Total Debt3.26M18.1M18%
TECHNICAL ANALYSIS
Technical Analysis
ACRVAURA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 8 days ago
87%
Bullish Trend 8 days ago
78%
Declines
ODDS (%)
Bearish Trend 19 days ago
89%
Bearish Trend 2 days ago
83%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ACRV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AFYA15.270.17
+1.13%
Afya Limited
CAPR6.260.01
+0.16%
Capricor Therapeutics
LIN482.15-0.56
-0.12%
Linde plc
FAF65.42-1.17
-1.76%
First American Financial Corp
GBIO6.17-0.18
-2.83%
Generation Bio Co

AURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AURA has been loosely correlated with VRDN. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if AURA jumps, then VRDN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AURA
1D Price
Change %
AURA100%
-0.16%
VRDN - AURA
52%
Loosely correlated
-0.65%
IDYA - AURA
50%
Loosely correlated
-0.28%
BEAM - AURA
47%
Loosely correlated
-0.06%
MGTX - AURA
47%
Loosely correlated
+0.67%
DSGN - AURA
47%
Loosely correlated
+6.62%
More